11:58 AM ET
10-Q
Financial Results
Avai Bio Q2 2026 Results: Net Loss of $253K, Loss Narrows
Avai Bio, Inc. reported a net loss of $805,281 for the six months ended September 30, 2026, compared to a loss of $940,605 in the prior year period. The company remains in a development stage with zero revenue, a stockholders' deficit of $3,415,806, and is focused on acquiring and developing AI-based technologies.
- Key figure
- Net loss $253K